Abstract:Muscle wasting is often associated with chronic inflammation. Because tumor necrosis factor ␣ (TNF-␣) has been implicated as a major mediator of cachexia, its effects on C2C12 myocytes were examined. TNF-␣ activated nuclear factor-␬B (NF-␬B) and interfered with the expression of muscle proteins in differentiating myoblasts. Introduction of a mutant form of inhibitory protein ␬B␣ (I␬B␣) restored myo-genic differentiation in myoblasts treated with TNF-␣ or interleukin 1␤. Conversely, activation of NF-␬B by overexpression of I␬B kinase was sufficient to block myogenesis, illustrating the causal link between NF-␬B activation and inhibition of myogenic differentiation. The inhibitory effects of TNF-␣ on myogenic differentiation were reversible, indicating that the effects of the cytokine were not due to nonspecific toxicity. Treatment of differentiated myotubes with TNF-␣ did not result in a striking loss of muscle-specific proteins, which shows that myogenesis was selectively affected in the myoblast stage by TNF-␣. An important finding was that NF-␬B was activated to the same extent in differentiating and differentiated cells, illustrating that once myocytes have differentiated they become refractory to the effects of NF-␬B activation. These results demonstrate that inflammatory cytokines may contribute to muscle wasting through the inhibition of myogenic differentiation via a NF-␬B-dependent pathway.—Lan-matory cytokines inhibit myogenic differentiation through activation of nuclear factor-␬B. Muscle wasting, defined as the loss of skeletal muscle tissue, commonly occurs in chronic wasting syndromes, such as AIDS (1), cancer (2), chronic heart failure (3), and chronic obstructive pulmonary disease (4 – 6), and is an independent predictor of mortality. Remarkably, in many of these conditions muscle wasting is associated with chronic elevations in circulating inflamma-tory cytokines, in particular tumor necrosis factor ␣ (TNF-␣) (7–10). Muscle wasting is generally believed to result from disturbances in the energy or anabolism-catabolism balance. For example, imbalances in myofi-brillar protein synthesis and proteolysis have been demonstrated in experimental models of cancer ca-chexia (11, 12) and sepsis (13). Elevated levels of circulating inflammatory mediators, such as TNF-␣ and interleukin 1 (IL-1), were believed to trigger the events leading to muscle wasting in these models. In support of this, chronic administration of TNF-␣ or IL-1 induced weight loss and skeletal muscle wasting in rats (14). Muscle wasting may alternatively result from a decrease of the number of fibers. In support of this proposal, an increased prevalence of apoptotic myonu-clei has been associated with the loss of skeletal muscle tissue in muscular dystrophies and inflammatory myop-athies (15–17). In addition, …

TWEAK/Fn14 Regulates Denervation-Induced Skeletal Muscle Atrophy Through an “Inside-Out” Signaling Pathway

TWEAK/Fn14 Signaling Axis Mediates Skeletal Muscle Atrophy and Metabolic Dysfunction

The TWEAK/Fn14 signaling promotes skeletal muscle wasting during cancer cachexia

TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine

Dysregulation of Tweak and Fn14 in skeletal muscle of spinal muscular atrophy mice

TWEAK and Fn14 are overexpressed in immune-mediated necrotizing myopathy: implications for muscle damage and repair

Nuclear factor-kappa B signaling in skeletal muscle atrophy

Inhibition of IL-6/JAK/STAT3 pathway rescues denervation-induced skeletal muscle atrophy

HMGB1/autophagy Pathway Mediates the Atrophic Effect of TGF-β1 in Denervated Skeletal Muscle

Inflammatory Cytokine-Induced Muscle Atrophy and Weakness Can Be Ameliorated by an Inhibition of TGF-β-Activated Kinase-1

Cytokine Signaling in Skeletal Muscle Wasting

Proteomic and Bioinformatic Analysis of Differentially Expressed Proteins in Denervated Skeletal Muscle

Fn14 promotes myoblast fusion during regenerative myogenesis

Tenotomy-induced muscle atrophy is sex-specific and independent of NFκB

TWEAK/Fn14 axis is an important player in fibrosis

Muscle wasting in disease: molecular mechanisms and promising therapies

The role of TGF-β signaling in muscle atrophy, sarcopenia and cancer cachexia

Microarray Analysis of Gene Expression Provides New Insights Into Denervation-Induced Skeletal Muscle Atrophy

TAK-1/p38/nNFκB signaling inhibits myoblast differentiation by increasing levels of Activin A

Inflammatory Cytokines Inhibit Myogenic Differentiation through Activation of Nuclear Factor-␬b

Muscle inflammation is regulated by NF-κB from multiple cells to control distinct states of wasting in cancer cachexia